A Clinical Study to Compare the Safety and Pharmacokinetics of SHR-1314 Injection in Healthy Subjects at Different Specifications Devices

NCT06182384 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate-to-Severe Plaque Psoriasis

Interventions

DRUG: SHR-1314
DRUG: SHR-1314

Sponsor

Suzhou Suncadia Biopharmaceuticals Co., Ltd.